Zurletrectinib has also been included in the “SPARK Program” by the CDE, a pilot initiative to encourage the development of pediatric anti-tumor drugs.

Aalto University scientists have created a laser-based treatment that uses gentle heat to stop the progression of dry macular degeneration. The approach stimulates the eye’s natural cleanup and repair ...

Infantile fibrosarcoma (IFS) represents the most common non-rhabdomyosarcoma soft tissue tumor, with 80% of diagnoses under the first year of life. In contrast with adult fibrosarcoma, IFS has lower ...

Victor Sung, M.D., director of the Division of Movement Disorders in the University of Alabama at Birmingham Department of Neurology and director of the UAB Huntington’s Disease Clinic, reacted to the ...

With informed consent, you generally have the right to seek a second opinion or refuse treatment unless refusing poses a danger to the community or a court of law declares you “mentally incompetent.” ...

Here is described a case of ameloblastic fibrosarcoma (AFS) affecting the posterior mandible of a woman who was treated surgically and recovered without signs of recurrence or metastasis after 12 ...

Preliminary findings suggest that OH2 monotherapy is safe, with promising responses observed when combined with HX008 in locally advanced or metastatic sarcoma. Findings from a phase 1/2 study ...

Introduction: NF-κB plays a pivotal role in the progression of cancers, including myosarcomas such as fibrosarcoma. Plants possess considerable potential for the provision of chemotherapeutic effects ...

Study demonstrated that a previously approved drug could replace chemotherapy as a first-line therapy for certain cancers IFS, a rare soft-tissue sarcoma, typically presents as a localized tumor.